Monday, May 18, 2015 11:48:31 AM
3D Systems to Host Analyst Event
ROCK HILL, S.C., May 15, 2015 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today that it plans to host an analyst event on Tuesday, May 19, 2015, from 1:00 p.m. until approximately 4:00 p.m. PT at its Wilsonville, Oregon location.
The event will feature presentations by 3DS' senior management, including:
-- Avi Reichental, President and CEO
-- Mark Wright, Executive Vice President, Chief Operating Officer
-- Kevin McAlea, Executive Vice President and Chief Operating Officer,
Healthcare
-- Jeff Blank, Vice President, Engineering and Chief Development Officer
-- Chuck Hull, Executive Vice President, Chief Technology Officer
Following the presentation, attendees will have an opportunity to meet and talk with the company's new CFO Dave Styka and to tour 3DS' Wilsonville facility.
For those unable to attend the event, the executive presentations and subsequent question and answer session will be webcast live on May 19, beginning at approximately 1:00 p.m. PT and concluding at approximately 3:00 p.m. PT. A link to the webcast and slide presentation will be available on the investor relations section of 3D Systems' website at www.3dsystems.com/investor.
Recent DDD News
- 3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- 3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing • GlobeNewswire Inc. • 03/22/2024 12:00:00 PM
- Wilting Expands Production Capacity with Three DMP Flex 350 Printers • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:14:53 PM
- 3D Systems Announces Additional Partial Repurchase of Convertible Senior Notes • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 11:06:41 AM
- 3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited) • GlobeNewswire Inc. • 02/27/2024 11:15:41 PM
- 3D Systems Introduces Industry’s First Multi-material, One-piece Jetted Denture Solution • GlobeNewswire Inc. • 02/21/2024 09:05:00 PM
- 3D Systems Announces Date of Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/14/2024 09:28:07 PM
- Systemic Bio to Present Innovative Human-relevant Datasets from h-VIOS™ Platform at SOT and AACR 2024 Annual Meetings • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- WeAreAM Adds DMP Flex 350 Dual to Manufacturing Workflow — Expanding Addressable Applications • GlobeNewswire Inc. • 01/29/2024 01:30:00 PM
- 3D Systems Announces Executive Leadership Changes • GlobeNewswire Inc. • 01/10/2024 02:00:00 PM
- 3D Systems to Attend 26th Annual Needham Growth Conference • GlobeNewswire Inc. • 01/08/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:12:53 PM
- 3D Systems Announces Organization Changes and New Executive Leadership Appointments • GlobeNewswire Inc. • 12/13/2023 10:57:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:32:26 PM
- 3D Systems Announces Partial Repurchase of Convertible Senior Notes • GlobeNewswire Inc. • 12/06/2023 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 08:11:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:13:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:09:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:44:05 PM
- 3D Systems Receives FDA Clearance for NextDent® Base • GlobeNewswire Inc. • 11/15/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM